VESILUTE 20 MG

Vesilute 20 mg – Bladder Tissue Peptide Bioregulator | Peptide Hubs

Vesilute is a synthetic peptide bioregulator designed for bladder and lower urinary tract tissue support. This 20 mg (2 mL) vial by Peptide Hubs is offered as a high-purity compound for experimental use in studies involving epithelial regeneration, urinary function, and age-related decline of bladder tissue. It mimics natural peptides derived from bladder tissue and is used in research investigating organ-specific cellular regeneration.

What Is Vesilute?

Vesilute is part of a class of peptides known as cytomedines—organ-specific bioregulators that target gene expression and cellular renewal in specific tissues. In this case, Vesilute is studied for its effects on bladder urothelial lining, detrusor muscle tone, and urinary tract epithelium. Research indicates it may support tissue restoration, reduce inflammation, and normalize voiding functions.

According to studies on peptide bioregulators, compounds like Vesilute may play a role in epigenetic modulation, helping restore normal cellular functions in aging or damaged organs.

Key Research Applications

• Bladder tissue repair and regeneration
• Normalization of urothelial function
• Support in urinary incontinence and LUTS models
• Anti-inflammatory support in urological tissue
• Anti-aging applications for urinary tract health

Recommended Dosage Protocol in Research

In research settings, Vesilute is typically dosed at 10–20 mg per week, administered subcutaneously in 2–3 injections per week. Research duration may vary from 2 to 6 weeks depending on tissue regeneration goals and study design. The peptide is non-hormonal and acts through localized gene expression influence.

Suggested Peptide Combinations for Research

To expand the regenerative potential of Vesilute, researchers often combine it with other tissue- or neuro-supportive peptides:

• BPC-157 – promotes tissue healing and anti-inflammatory action
• GHK-Cu – supports angiogenesis and connective tissue repair
• Selank – for neuroimmune support in pelvic floor and urogenital studies
• Thymalin – immune-endocrine balance and systemic peptide support
• AOD 9604 – supports metabolic recovery and organ peptide synergy

Safety Profile

Vesilute has demonstrated excellent safety in preclinical research. It does not interfere with hormonal pathways, nor does it cause hepatotoxicity or cardiovascular stress. Being an organ-targeted bioregulator, it is systemically neutral and has no androgenic or estrogenic effects. It is designated for laboratory research use only and is not approved for human use.

USA Domestic Shipping | GMP Quality

Peptide Hubs ensures rapid and secure USA domestic shipping of Vesilute 20 mg and all bioregulator peptides. Each batch is produced under strict GMP standards. For researchers investigating bladder health, urothelial repair, or age-related urinary issues, Vesilute is a well-supported addition to the peptide toolkit.

Frequently Asked Questions